# Cell Source, Inc. (CLCS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CLCS/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -5.01M | $ -2.82M | $ 10.07M | $ -18.80M |
| 2023 | $ 0 | $ -5.75M | $ -2.54M | $ 9.25M | $ -15.61M |
| 2022 | $ 0 | $ -5.71M | $ -3.51M | $ 7.90M | $ -12.63M |
| 2021 | $ 0 | $ -6.51M | $ -4.02M | $ 6.47M | $ -9.83M |
| 2020 | $ 0 | $ -5.81M | $ -3.53M | $ 4.81M | $ -7.95M |
| 2019 | $ 0 | $ -5.78M | $ -3.34M | $ 2.60M | $ -5.74M |
| 2018 | $ 0 | $ -2.69M | $ -2.64M | $ 2.67M | $ -4.92M |
| 2017 | $ 0 | $ -4.15M | $ -3.08M | $ 2.32M | $ -4.56M |
| 2016 | $ 0 | $ -1.33M | $ -2.06M | $ 3.09M | $ -6.24M |
| 2015 | $ 0 | $ -3.52M | $ -2.81M | $ 1.27M | $ -5.76M |
| 2014 | $ 0 | $ -5.73M | $ -4.41M | $ 100.0K | $ -3.78M |
| 2013 | $ 0 | $ -1.77M | $ -33.3K | $ 0 | $ 11.3K |
| 2012 | $ 0 | $ -35 | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.54 |
| Liabilities / Eq | -1.02 |
| Current Ratio | 0.02 |

## Other views

- [Metrics](https://sponda.capital/en/CLCS.md)
- [Charts](https://sponda.capital/en/CLCS/charts.md)
- [Compare](https://sponda.capital/en/CLCS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.